Finally, the structure of a catalytically active form of DUSP26 presented here may serve as a useful template for structure-based design of anti-cancer therapeutic agents against human tumors bearing wild-type p53 such as neuroblastoma. The gene discussed is TP53; the disease is neuroblastoma.